Page last updated: 2024-08-24

darglitazone and c-peptide

darglitazone has been researched along with c-peptide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boden, G; Chaiken, RL; Eckert-Norton, M; Gelfand, RA; Lebovitz, HE; Pasmantier, R; Ryan, I1

Trials

1 trial(s) available for darglitazone and c-peptide

ArticleYear
Metabolic effects of darglitazone, an insulin sensitizer, in NIDDM subjects.
    Diabetologia, 1995, Volume: 38, Issue:11

    Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Fatty Acids, Nonesterified; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Obesity; Thiazoles; Thiazolidinediones

1995